Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | GLP1R | P43220 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13406205 | 0.76 | KDM4E (0.50) | KDM4EMAPK1KMT2AL3MBTL1CYP1A2 | |
| SCHEMBL1304956 | 0.75 | HTT (0.47) | KMT2ACYP1A2ALDH1A1TARBP2MAPT | |
| SCHEMBL9869495 | 0.74 | CA12 (0.42) | KDM4EMAPK1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL2409453 | 0.73 | KDM4E (0.66) | KDM4EMAPK1KMT2AL3MBTL1CYP1A2 | |
| SCHEMBL20657515 | 0.73 | KDM4E (0.48) | KDM4EMAPK1KMT2AL3MBTL1CYP1A2 | |
| SCHEMBL18560495 | 0.73 | KDM4E (0.47) | KDM4EMAPK1KMT2AL3MBTL1CYP1A2 | |
| SCHEMBL7361832 | 0.72 | SMN1; SMN2 (0.50) | KDM4EMAPK1KMT2ACYP1A2ALDH1A1 | |
| SCHEMBL6366583 | 0.72 | KDM4E (0.55) | KDM4EMAPK1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL6644254 | 0.72 | KDM4E (0.53) | KDM4EMAPK1KMT2AL3MBTL1CYP1A2 | |
| SCHEMBL10003092 | 0.71 | ALDH1A1 (0.42) | KDM4EMAPK1CYP1A2ALDH1A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1290448-B1 | RARE EARTH METAL CRYPTATES SHOWING REDUCED FLUORESCENCE QUENCHING | CIS BIO INT (FR) | 2007-11-07 | — | — | EP | disclosed |
| US-7087384-B2 | Rare earth metal cryptates which are not very sensitive to the fluorescence quenching | CIS BIO INTERNATIONAL (FR) | 2006-08-08 | — | — | US | disclosed |
| US-20040092726-A1 | Novel rare earth metal cryptates which are not very sensitive to the fluorescence quenching | CIS BIO INTERNATIONAL (FR) | 2004-05-13 | — | — | US | disclosed |
| EP-1290448-A2 | RARE EARTH METAL CRYPTATES SHOWING REDUCED FLUORESCENCE QUENCHING | CIS BIO INTERNATIONAL (FR) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001096877-A2 | RARE EARTH METAL CRYPTATES SHOWING REDUCED FLUORESCENCE QUENCHING | CIS BIO INTERNATIONAL (FR) | 2001-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092726-A1 | Novel rare earth metal cryptates which are not very sensitive to the fluorescence quenching | SQOR, MCU, NDUFS4 | KDM4E 3781/4885MAPK1 4004/4885KMT2A 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.